Filing Flows › Health Care › Mannatech (MTEX)
Mannatech (MTEX) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 12, 2026 · Mannatech (MTEX) Q2 2026 earnings results →
Q2 2026 Revenue up 4% year over year to $26.6M · 4¢ of every $1 of revenue kept as net profit · operating margin 3.7%
Mannatech made $26.6M in Q2 2026 (+4% Y/Y): Product $26.2M, Product and Service, Other $400K, Associate Service Fees $100K. Operating margin 3.7%, net earnings $1.0M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 12, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $26.6M in Q2 2026, up 4% year over year and up 7% from the previous quarter. Product was the largest line at 98% of revenue. Product added $1.0M year over year (up 4%), 103% of the total change.
Gross margin was 76.9%, up 3.3 points from Q2 2025. Operating profit was $1.0M, a 3.7% margin (up 9.4 points year over year). Operating expenses fell 4% while revenue rose 4%. Net earnings were $1.0M. The effective tax rate was 12.9%.
Operating cash flow was −$792K. Non-cash charges added back $259K of depreciation and amortization and $54K of share-based compensation. Working capital and other items used $2.1M. Capital expenditures of $10K exceeded it, leaving free cash flow of −$802K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 12, 2026 | $26.6M | +4% | 3.7% | $1.0M | −$792K |
| Q1 2026 | 10-Q | May 14, 2026 | $24.9M | -6% | -0.7% | $950K | $1.1M |
| Q4 2025 | 10-K | Apr 15, 2026 | $26.6M | -8% | -0.6% | −$11.3M | −$289K |
| Q3 2025 | 10-Q | Nov 12, 2025 | $29.2M | -8% | 6.9% | $1.9M | $2.4M |
| Q2 2025 | 10-Q | Aug 12, 2025 | $25.7M | -7% | -5.6% | −$4.3M | −$3.7M |
| Q1 2025 | 10-Q | May 13, 2025 | $26.6M | -10% | -3.1% | −$1.5M | −$1.4M |
| Q4 2024 | 10-K | Mar 26, 2025 | $29.0M | -11% | 3.0% | $2.3M | −$219K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Mannatech
Mannatech, Incorporated ("Mannatech" or the "Company") is a global wellness solution provider, which was incorporated and began operations in November 1993. We develop and sell innovative, high quality, proprietary nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. We currently sell our products in three regions: (i) the Americas (the United States, Canada and Mexico); (ii) Europe/the Middle East/Africa (“EMEA”) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden and the United Kingdom); and (iii) Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Thailand, Taiwan, Hong Kong, and China).
In its own words, from its 10-K, filed Apr 15, 2026.
Mannatech against its Medicinal Chemicals & Botanical Products peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +4% against the peers' median +7%. Operating margin: 3.7% against the peers' median 3.7%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| MTEX Mannatech | Q2 2026 | $26.6M | +4% | 3.7% |
| CURLF Curaleaf Holdings | Q3 2026 | $353M | +11% | 0.8% |
| TLRY Tilray Brands | Q1 FY27 | $257M | +23% | -9.4% |
| TRLV Trulieve Cannabis | Q3 2026 | $230M | -20% | 18.5% |
| USNA Usana Health Sciences | Q2 2026 | $223M | -5% | -9.0% |
| AAWH Ascend Wellness Holdings | Q2 2026 | $126M | -0.9% | 4.2% |
| CRON Cronos Group | Q3 2026 | $83.9M | +72% | 10.8% |
| CGC Canopy Growth | Q2 FY27 | $71.1M | +20% | -23.1% |
| JUSH Jushi Holdings | Q3 2026 | $70.5M | +7% | 5.0% |
Source: Mannatech 10-Q on SEC EDGAR · CIK 1056358 · Medicinal Chemicals & Botanical Products
13F: who owns MTEX and who is buying
More on MTEX
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results